Seres Therapeutics (MCRB) Stock: Buy, Sell, or Hold?
MCRB - Seres Therapeutics, Inc.
$2.93
-0.42 (-12.54%)
▼
5d:
-19.06%
30d:
-43.44%
90d:
-62.14%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When MCRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MCRB is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MCRB is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MCRB is currently trading at $2.93, which is considered oversold relative to its 30-day fair value range of $3.74 to $5.29.
Technical Outlook: Technically, MCRB is in a strong downtrend. Immediate support is located at $2.83, while resistance sits at $4.33. Short-term momentum is weak, with the stock down 12.5% recently.
Market Sentiment: MCRB scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+480.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MCRB is in a strong downtrend. Immediate support is located at $2.83, while resistance sits at $4.33. Short-term momentum is weak, with the stock down 12.5% recently.
Market Sentiment: MCRB scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+480.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.74 -
$5.29
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding MCRB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.5%)
- BULLISH: Trading 480.2% below Wall St target ($17.00)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.74 -
$5.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.83
Resistance Level
$4.33
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.59
Wall Street Target
$17.00
(+480.2%)
Revenue Growth (YoY)
-93.4%
Earnings Growth (YoY)
-91.9%
Share & Embed Analysis
Last updated: October 02, 2026 8:32 AM ET
Data refreshes hourly during market hours. Next update: 9:32 AM
Data refreshes hourly during market hours. Next update: 9:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MCRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 45 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$139 | 66 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 54 HOLD |
Advanced MCRB Option Strategies
Professional options setups generated by AI based on today's MCRB price and gamma walls.
